Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ACALA is a premium beverage company based in Lithuania that specializes in the production of craft sparkling teas through advanced fermentation processes. Founded in 2019, the company positions its products as sophisticated, non-alcoholic alternatives to traditional wines and champagnes, specifically targeting the fine dining and wellness sectors. Their production methodology utilizes high-quality ingredients such as Fire Tea, kombucha cultures, and various botanicals to create complex flavor profiles without the use of artificial additives. ACALA's business model focuses on the intersection of gastronomy and health, catering to consumers seeking functional, low-sugar, and alcohol-free beverage options. The company has successfully expanded its distribution across Europe and into international markets, supported by venture capital investment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Acala Tea Co.